Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
dualCAR-NK19/70 in r/r B-cell Non-Hodgkin Lymphoma
NCT05842707Phase 2Recruiting
- Start
- Jan 2023
- Primary completion
- Jan 2028
- Modality
- Gene Editing, Gene Silencing, Lymphokine-Activated Killer Cells
- Countries
- 1
01
Overview
A Phase 2 trial of CB dualCAR-NK19/70 in B-cell non-Hodgkin lymphoma. Started Jan 2023; status: recruiting.
02
Drugs
CB dualCAR-NK19/70
03
Conditions
B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT05842707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05842707.